Page 28 - GTM-1-2
P. 28

Global Translational Medicine                                IGF-1 and IGFBP-3 levels are correlated with eGFR



            longitudinal subgroup analysis to clarify further the trend   References
            of IGF-1 changes in patients with severe renal impairment.
                                                               1.   Petersmann A, Muller-Wieland D, Muller UA, et al., 2019,
            5. Conclusions                                        Definition, classification and diagnosis of diabetes mellitus.
                                                                  Exp Clin Endocrinol Diabetes, 127: S1–S7.
            Serum IGF-1 and IGFBP-3 were positively correlated with      https://doi.org/10.1055/a-1018-9078
            eGFR in patients with T2DM. Although there has been
            an increased understanding of the function of IGF-1and   2.   Compston J, 2018, Type  2 diabetes mellitus and bone.
                                                                  J Intern Med, 283: 140–153.
            IGFBP-3, there are still many unanswered questions about
            their effects on renal function in patients with T2DM.      https://doi.org/10.1111/joim.12725
            Therefore, whether serum IGF-1 can be used for the   3.   Thomas MC, Brownlee M, Susztak K, et al., 2015, Diabetic
            measurement and assessment  of renal  function requires   kidney disease. Nat Rev Dis Primers, 1: 15018.
            further evaluation in prospective large-scale studies.     https://doi.org/10.1038/nrdp.2015.18

            Acknowledgments                                    4.   Kramer HJ, Nguyen QD, Curhan G,  et al., 2003, Renal
                                                                  insufficiency in the absence of albuminuria and retinopathy
            Not applicable.                                       among adults with Type  2 diabetes mellitus.  JAMA,
                                                                  289: 3273–3277.
            Funding
                                                                  https://doi.org/10.1001/jama.289.24.3273.
            This work was supported by the fund project in the State   5.   Garg AX, Kiberd BA, Clark WF, et al., 2002, Albuminuria and
            Key Laboratory of Pathogenesis, Prevention, and Treatment   renal insufficiency prevalence guides population screening:
            of High Incidence Diseases in Central Asia (name of the   Results from the NHANES III. Kidney Int, 61: 2165–2175.
            fund: The role of TCF7L2/Wnt/GLP-1 signaling pathway
            and environmental factors in the pathogenesis of type-2      https://doi.org/10.1046/j.1523-1755.2002.00356.x
            diabetes in Kazakhs; no. SKL-HIDCA-2019-15).       6.   MacIsaac RJ, Tsalamandris C, Panagiotopoulos S,  et al.,
                                                                  2007, Nonalbuminuric renal insufficiency in Type 2 diabetes.
            Conflict of interest                                  Diabetes Care, 27: 195–200.

            The authors report no conflicts of interest in this work.     https://doi.org/10.2337/diacare.27.1.195
                                                               7.   Rahmani J, Montesanto A, Giovannucci E,  et al., 2022,
            Author contributions                                  Association between IGF-1  levels  ranges and  all-cause
            Conceptualization: Sheng Jiang                        mortality: A meta-analysis. Aging Cell, 21: e13540.
            Formal analysis: Sheng Jiang, Jing Yang               https://doi.org/10.1111/acel.13540
            Investigation: Jing Yang                           8.   Liu H, Gu H, Kutbi EH, et al., 2021, Association of IGF-1
            Writing – original draft: Sheng Jiang, Jing Yang      and IGFBP-3 levels with gastric cancer: A systematic review
            Writing – review & editing: Jing Yang                 and meta-analysis. Int J Clin Pract, 75: e14764.

            Ethics approval and consent to participate            https://doi.org/10.1111/ijcp.14764
                                                               9.   Qiang J, Kai L, Lulu H, et al., 2020, The effect of resistance
            The study was performed in accordance with the ethical   training on serum insulin-like growth factor 1(IGF-1):
            guidelines of the 1975  Declaration of Helsinki and was   A  systematic review and meta-analysis.  Complement Ther
            reviewed and approved by the Human Research Ethics    Med, 50: 102360.
            Committee of the Affiliated Hospital of Xinjiang Medical      https://doi.org/10.1016/j.ctim.2020.102360
            University (K202205-11),  and informed consent was
            obtained from all patients with type  2 diabetes mellitus   10.  Aguirre GA, Gonzalez-Guerra JL, Espinosa L, et al., 2018,
                                                                  Insulin-like growth factor 1 in the cardiovascular system.
            before their participation.
                                                                  Rev Physiol Biochem Pharmacol, 175: 1–45.
            Consent for publication                               https://doi.org/10.1007/112_2017_8
            Not applicable.                                    11.  Nambam B, Schatz D, 2018, Growth hormone and insulin-
                                                                  like growth factor-I axis in Type 1 diabetes. Growth Horm
            Availability of data                                  IGF Res, 38: 49–52.

            The data used to support the findings of this study are      https://doi.org/10.1016/j.ghir.2017.12.005
            available from the corresponding author on request.  12.  Akcali A, Bal B, Erbagci B, 2017, Circulating IGF-1,


            Volume 1 Issue 2 (2022)                         8                       https://doi.org/10.36922/gtm.v1i2.62
   23   24   25   26   27   28   29   30   31   32   33